Bridgewater Associates, LP
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1350694
Westport, CT
Position in ADPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
10,022
-55.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $61,970,170 across 16 Diagnostics & Research names. ADPT ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
33,528 | $17,650,480 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
15,605 | $8,264,251 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
12,948 | $6,491,609 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
26,210 | $5,064,296 | |
| 5 | DHR |
Danaher Corp /De/
|
25,684 | $4,892,288 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
3,146 | $4,019,046 | |
| 7 | VCYT |
Veracyte, Inc.
|
58,289 | $3,423,312 | |
| 8 | A |
Agilent Technologies, Inc.
|
22,889 | $3,040,345 |
All Filings in ADPT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 40,087 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | — | 89,707 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 265,491 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | — | 151,254 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||